drugset / Trial / NCT03246971
Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study evaluates the safety and effectiveness of Wafermine™ for post-bunionectomy or post-abdominoplasty pain over a 24 hours period. For subjects undergoing bunionectomy, 2 out of 3 subjects will receive Wafermine™ and 1 out of 3 subjects will receive placebo. For subjects undergoing abdominoplasty, 3 out of 4 subjects will receive Wafermine™ and 1 out of 4 subjects will receive placebo.
Timeline
- Start
- 2017-08-24
- Primary completion
- 2018-07-12
- Completion
- 2018-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 25 mg | Other |
| Subject | Ketamine | Small molecule | 50 mg | Other |
| Subject | Ketamine | Small molecule | 75 mg | Other |